Investor Presentaiton slide image

Investor Presentaiton

Financials changing diabetes Investor Presentation First nine months of 2018 Slide 110 1. Sales growth 111 2. Operating Profit growth 113 3. Cost distribution 114 4. COGS & CAPEX as percent of sales 115 5. Cash return to shareholders 6. Currency impact 7. Ownership structure 117 118 121 novo nordisk
View entire presentation